Related Experiment Video
Updated: Jan 4, 2026
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
Paratesticular leiomyosarcoma: A clinical case report.
N H Kolev1, V R Dunev1, M P Karaivanov1
1Medical University Pleven, "Georgi Kochev"8A str, 5800, Bulgaria.
A rare paratesticular leiomyosarcoma (LMS) in a 62-year-old man was diagnosed and graded as high-grade (grade 3). This case highlights the diagnostic and therapeutic challenges posed by this uncommon malignancy.
Area of Science:
- Oncology
- Pathology
- Urologic Oncology
Background:
- Paratesticular leiomyosarcoma (LMS) is an exceptionally rare soft tissue sarcoma.
- These tumors present unique diagnostic and management challenges due to their infrequency.
Observation:
- A case study of a 62-year-old male patient with paratesticular LMS localized to the right hemiscrotum.
- Comprehensive pathological and immunohistochemical analyses were performed.
- Tumor staging utilized the French Federation of Cancer Centres Sarcoma Grading System.
Findings:
- The paratesticular tumor was definitively diagnosed as leiomyosarcoma.
- Detailed histopathological and immunohistochemical characterization confirmed the tumor's nature.
- The final tumor grade was determined to be grade 3, indicating a high-grade malignancy.
Implications:
- This case underscores the rarity and complexity of diagnosing and treating paratesticular LMS.
- Accurate pathological and immunohistochemical assessment is crucial for appropriate grading and staging.
- Further research into optimal treatment strategies for paratesticular LMS is warranted.
More Related Videos
05:52Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024